Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 13, Issue 11, Pages 3138-3151
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-08-06
DOI
10.1074/mcp.m113.033217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
- (2015) Euan A. Stronach et al. NEOPLASIA
- Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
- (2012) Ahmed Y. Ali et al. Annals of the New York Academy of Sciences
- New Insight into P-Glycoprotein as a Drug Target
- (2012) Albert Breier et al. Anti-Cancer Agents in Medicinal Chemistry
- Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
- (2012) Nicole P. Chappell et al. JOURNAL OF PROTEOME RESEARCH
- Acquired Resistance to Peloruside A and Laulimalide is Associated with Downregulation of Vimentin in Human Ovarian Carcinoma Cells
- (2012) Arun Kanakkanthara et al. PHARMACEUTICAL RESEARCH
- Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
- (2012) Britta Stordal et al. PLoS One
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells
- (2010) Jhang Ho Pak et al. CANCER INVESTIGATION
- Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America.
- (2010) Megan A. Murphy et al. INTERNATIONAL JOURNAL OF CANCER
- Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method
- (2010) Fengming Gong et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
- (2010) Natini Jinawath et al. PLoS One
- Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
- (2010) Zhiqin Dai et al. PROTEOMICS
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
- (2009) Meng Li et al. BMC Medical Genomics
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA
- (2009) Fabio Arnesano et al. COORDINATION CHEMISTRY REVIEWS
- Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
- (2009) David S. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Proteomic Analysis of Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line and Its Resistant Counterpart A2780TC1 by 2D-DIGE: The Role of ERp57
- (2009) Lucia Cicchillitti et al. JOURNAL OF PROTEOME RESEARCH
- A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
- (2009) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: Prevention by thiol group protecting agents
- (2009) José B.A. Custódio et al. TOXICOLOGY
- A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines
- (2008) Michela Di Michele et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism
- (2008) X.-J. Liang et al. MOLECULAR CANCER RESEARCH
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now